Page last updated: 2024-10-22

albuterol and Drug-Induced Stevens Johnson Syndrome

albuterol has been researched along with Drug-Induced Stevens Johnson Syndrome in 2 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shariff, A1
Hillerson, D1
Ross, J1
Ayala-Pena, E1
Maggini, V1
Lombardi, N1
Lenti, MC1
Masi, S1
Trapani, S1
Pugi, A1
Mugelli, A1
Vannacci, A1

Other Studies

2 other studies available for albuterol and Drug-Induced Stevens Johnson Syndrome

ArticleYear
Stevens-Johnson syndrome secondary to isolated albuterol use.
    Cutis, 2017, Volume: 100, Issue:2

    Topics: Administration, Inhalation; Albuterol; Asthma; Bronchodilator Agents; Diagnosis, Differential; Human

2017
A case of pediatric Steven-Johnson Syndrome associated with albuterol consumption.
    International immunopharmacology, 2015, Volume: 27, Issue:1

    Topics: Albuterol; Asthma; Bronchodilator Agents; Child; Humans; Immunoglobulins, Intravenous; Male; Pharmac

2015